Vanderbilt physicist Charles Brau awarded FEL Prize at international conference

Photo by Billy Kingsley
Charles A. Brau, professor of physics and former director of the W.M. Keck Foundation Free-Electron Laser Center.



by Brenda Ellis

Charles A. Brau, professor of physics and former director of the W.M. Keck Foundation Free-Electron Laser Center at Vanderbilt University, recently received the FEL Prize at the 18th annual International Free-Electron Laser Conference in Rome.

"I am enormously pleased to be included with a group of individuals I respect very highly," said Brau, who has served on the conference's executive committee. More than 250 scientists worldwide attended the conference in August. The FEL Prize includes a monetary award and the responsibility of delivering the first plenary address at the 19th International FEL conference in Beijing.

Brau, co-inventor of the excimer laser, has made major contributions to the field of laser research. A former FEL project manager at the Los Alamos National Laboratory, he left the Quantum Institute at Santa Barbara, Calif., in 1988 to head the FEL research facility at Vanderbilt. His contributions to FEL projects at Los Alamos and at Vanderbilt were cited by the award committee.

The free-electron laser is a research instrument with special characteristics other lasers don't possess. Its light is emitted in very short pulses, which enhances the ability to control the heat it generates. Also, the wavelength of FEL beams can be adjusted precisely.

Until last year Brau directed the FEL development program at Vanderbilt. His expertise centers on laser construction and electron-beam physics. Project scientists use the free-electron laser for a variety of applications, including some exciting medical research in neurosurgery, ophthalmology, otolaryngology and dermatology.

One project begun by Vanderbilt physician Frank Carroll and continued with Brau's support has attracted a great deal of interest. The development of monochromatic X-rays could have enormous impact on medical diagnostics because it will improve the contrast between tissues, Brau said. For example, it is hoped that with the use of the FEL, breast lesions not only can be detected but also the determination of whether a lesion is malignant or benign can be made without biopsy.

Brau's research emphasis as director of Vanderbilt's FEL center had concentrated on getting the large machine in commission. He currently is building a smaller, different FEL that will be used to demonstrate some basic physics principles. "Smaller machines can be more exciting than large ones because you can make progress faster and take bigger risks," said Brau. "There's not so much time and money at stake."

This document last updated Jan. 20, 1997